Synonyms: | |
Status: | Approved (2019) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | L01EX15 |
UNII: | 6783M2LV5X |
InChI Key | JGWRKYUXBBNENE-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H15ClF3N5 |
Molecular Weight | 417.82 |
AlogP | 5.23 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 66.49 |
Molecular species | NEUTRAL |
Aromatic Rings | 4.0 |
Heavy Atoms | 29.0 |
Primary Target | |
---|---|
colony stimulating factor 1 receptor | |
KIT proto-oncogene, receptor tyrosine kinase |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase PDGFR family
|
- | 11-20 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Synovitis, Pigmented Villonodular | 3 | D013586 | ClinicalTrials |
Giant Cell Tumors | 3 | D005870 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Hodgkin Disease | 2 | D006689 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Neurilemmoma | 1 | D009442 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Arthritis, Rheumatoid | 1 | D001172 | ClinicalTrials |
Gastrointestinal Stromal Tumors | 1 | D046152 | ClinicalTrials |
Liver Diseases | 0 | D008107 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1029044-16-3 |
ChEBI | 145373 |
ChEMBL | CHEMBL3813873 |
DrugBank | DB12978 |
DrugCentral | 5343 |
FDA SRS | 6783M2LV5X |
Guide to Pharmacology | 8710 |
PDB | P31 |
PubChem | 25151352 |
SureChEMBL | SCHEMBL1267310 |
ZINC | ZINC000115705166 |